Ondansetron Tablet, Orally Disintegrating
Product Images NDC 71205-713

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 71205-713). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

71205-713-10 (Ondansetron Od Fig4)

71205-713-10 (Ondansetron Od Fig4)
Ondansetron ODT 8 mg orally disintegrating tablets label by Proficient Rx LP. The label states the package contains 10 tablets, each containing 8 mg of Ondansetron USP. Tablets are described as white to off-white, round, debossed with '7' on one side and 'E' on the other with an embossed circular edge. Distributed by Rising Health, LLC, made in India, with storage instructions at 20°-25°C.*
FDA Label Image

Chemical Structure (Ondansetronod Str)

Chemical Structure (Ondansetronod Str)
Chemical structure of Ondansetron, an active pharmaceutical ingredient. The diagram shows the molecular arrangement including a fused ring system, a ketone group, and a methyl-substituted triazole ring.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.